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Point-of-care sensors are used in clinical applications for diagnosing and monitoring 
health conditions. For example, a point-of-care sensor for therapeutic drug monitoring 
of the clozapine antipsychotic can reduce burdens from guidelines suggesting routine 
monitoring of this medication. However, when measuring chemical markers in 
complex fluids, there are challenges related to decreased sensor performance due to 
chemical interference. This work presents a methodology for identifying individual 
interfering species. A set of cross-reactive electrochemical sensors were developed, 
whose diversified responses provide a fingerprint-type pattern capable of 
differentiating various species. By mapping the multidimensional responses, patterns 
from complex solutions were discerned and matched to those of individual species. 
Applying this methodology to clozapine sensing in blood, a major source of chemical 
interference was identified. The understanding matrix components that cause 
interference can guide the design of reliable sensing systems and can be integrated 
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Chapter 1: Introduction 
 
1.1 Motivation and Objectives 
The motivation behind this work lies in the need for methods and guidance in relation 
to the design of sensors for testing complex solutions, where a large number of 
unknown and potentially interfering species are present. When measuring chemical 
information in biological fluids, challenges of interference from other species in the 
solution arise, especially in sensing applications where no biological recognition 
elements exist. An understanding of the species in these complex matrices that affect 
a particular sensor system is useful in guiding its design. 
 
This thesis demonstrates a study of interfering species for the application of real-time 
therapeutic drug monitoring (TDM), which is used to monitor the efficacy and safety 
of drug treatments. The antipsychotic clozapine (CLZ) is a fitting example of the need 
of frequent TDM in schizophrenia. It is the most effective antipsychotic for 
treatment-resistant schizophrenia and because of its narrow therapeutic range frequent 
measurement of CLZ blood level is recommended [1]. CLZ is currently routinely 
measured by trained professionals at centralized laboratory facilities [2]. However, 
the iterative nature of this practice creates a burden for patients and medical 
professionals. Thus, a faster and more convenient POC monitoring platform that can 
be employed on-site or at home has the potential to decrease the burden and improve 




addresses selectivity issues that arise from interfering species present in blood serum 
samples with regard to CLZ blood monitoring. 
 
The objective of this thesis is to demonstrate a methodology for characterizing 
interfering species in electrochemical sensors, validated in the application of CLZ 
antipsychotic TDM in blood serum. The methodology, illustrated in Figure 1, begins 
with a coarse screening of interfering species relevant to CLZ sensing and proceeds 
with increased characterization rigor as the interfering species are narrowed down. 
The next stage of this methodology uses cross-reactive sensors to discern and match 
multidimensional patterns across buffer and complex fluid sample matrices. By 
matching the buffer and complex fluid responses, individual interfering species 
present in complex matrices (i.e., serum is composed of hundreds of species) can be 
identified. A feedback loop allows for various iterations of screening and matching. 
This multi-level test provides patterns that can be classified to particular species of 
interest. The results will help guide more targeted sensor design as well as future 
integration with sensor array pattern analysis tools, such as chemometric models. 
 
 
 Figure 1. Schematic representing the systematic methodology for studying the effect of the presence of 
interfering species (IS) presence on the CLZ measurement by matching buffer-based and serum studies 
through the use of cross-reactive sensors (CRS). A feedback loop enables various iterations of 





In this section, the context of the thesis research is established. The main POC 
sensing paradigms and current challenges regarding sample interference in complex 
matrices are reviewed. The concept of TDM as it relates to CLZ management is 
introduced. Lastly, the sensing methods of this study (electrochemical sensing and 
sensor arrays) are discussed. 
 
1.2.1 Point-of-Care Sensors for Blood Analysis 
1.2.1.1 Overview  
Point-of-Care (POC) sensors for blood analysis, such as in vitro diagnostics (IVD), 
are real-time devices used to maintain health, manage disease or monitor therapy and 
are decentralized, meaning that they can be carried out without the need for 
laboratory professionals and central facilities [3]. Rather, they are employed either in 
a near-patient setting (i.e., clinic, doctor’s office, pharmacy) or at home (i.e., 
glucometers, pregnancy tests). The advantages of POC technologies include faster 
results and therapeutic interventions, improved patient compliance, decreased hospital 
visits, better quality of life, and reduced cost [3-5]. The devices are designed to test 
one or multiple blood components such as proteins, nucleic acids, metabolites, drugs, 
dissolved gases, cells, and ions in biological fluids (i.e., blood, saliva, urine) [3].  
Ideal POC devices contain inexpensive platforms (i.e., disposable cartridges) that 
include microfluidic flow control, sensor elements, and readout capabilities. The 





The general lock-and-key design of sensor elements for measurement of biological 
analytes consists of a recognition element and a transducer, which is coupled to a 
signal readout [6, 7]. The recognition element is a component that interacts (i.e., binds 
or recognizes) with the analyte, imparting selectivity for the analyte in the presence of 
other species in complex biological fluids. Some examples of recognition elements 
commonly used in blood analysis include enzymes, antibodies and proteins. The 
transducer is a detector element that transforms the signal resulting from the 
interaction of the analyte with the recognition element into a signal that is 
measurable. Examples of common transducers include optical, piezoelectric, and 
electrochemical sensing methods [7]. The optimal choice of recognition and 
transducer elements should correspond to acceptable selectivity and sensitivity 
requirements depending on the application [8].  For instance, the physiological range 
of analyte concentrations, sample processing and component stability limitations, 
desired sensing time, and interference from sample components are some of the 
considerations for selecting an appropriate combination of elements for the sensor 
design [3, 6-8]. 
 
Two of the most well-known and successful POC tests include the blood glucose and 
pregnancy tests [3, 5]. Glucose sensors account for over 85% of the biosensors market 
[9], and they are used for diabetes monitoring. The concept of glucose monitoring is 
straightforward; people with diabetes test their glucose levels a few times a day, 
which helps them assess whether an insulin dose is needed at the particular time of 
day and helps to evaluate the success of diet and exercise. Glucose sensors are 




electrochemical sensors. The glucose molecules are recognized by the enzyme, which 
also serves as a transduction element since it is coupled to a secondary reaction.  The 
product of the second reaction is electrochemically detected and serves as an indirect 
measurement of the glucose concentration. 
 
The most common paradigm for biological sensor designs is the glucometer; thus, its 
design is typically used for sensing of a variety of other analytes. However, in cases 
where no specific recognition element is known for an analyte, a modified approach 
that is commonly employed is the use of indirect or synthetic recognition elements. 
These elements consist of sensitive coating materials that exhibit preferential 
properties for the analyte, and they are further discussed in section 1.2.3.2. 
 
1.2.1.2 Interference Challenges 
Interference is defined as a cause of significant bias in the analyte measurement due 
to the effect of another component or property of the sample [10]. Interferences in 
complex biologic matrix is a particular challenge of biological sensors [11, 12]. Some 
of the major modes of interference from species in a complex sample are illustrated in 
Figure 2. Direct detection of matrix components at the sensor surface is a major type 
of interference that can lead to chemical artifacts to ultimately project false positive 
results. Sensors with non-specific or no recognition elements are particularly 
susceptible to this type of interference and they are likely to suffer from a wider pool 
for interfering species due to the lack of selectivity. Deposition of species on the 




a decrease in sensor sensitivity and functionality. Lastly, species in the sample may 
react with each other prior to measurement due depending on storage and handling 






Potentially interfering species encompass endogenous species (i.e., naturally present 
in samples matrix) and exogenous species (i.e., originating outside the body). In 
serum, hundreds of endogenous species are present pertaining to the following 
classes: vitamins, minerals, amino acids, sugars, lipids, and proteins. Ascorbic acid, 
uric acid, oxygen and proteins are common endogenous interfering species [13-15]. 
Exogenous species include medications, ingested substances, and substances added 
during sample preparation [10]. Acetaminophen, maltose, salicylic acid, and xanthine 
are common exogenous interfering species [9, 13, 15, 16]. The concentration of both 
endogenous and exogenous species varies across the population, and thus the 
interference is variable from one individual to another. For this reason, understanding 
Figure 2. Illustration of four major modes of interference for the measurement of the analyte from 
interfering species (IS) in complex smaples: non-specific binding to recognition elements, fouling of 




the source of interferences can aid in accounting for interferent-specific effects on the 
sensor measurement.  
 
Some approaches that can be used to account for interfering species include chemical 
treatment, separation techniques (i.e., chromatography, extraction, filtration), 
manipulating molecular interactions at the sensor surface (i.e., size exclusion, 
electrostatic forces, catalytic behavior) or applying signal processing methods (i.e., 
deconvolution, noise filters, chemometrics). The first two methods involve the 
removal of the interfering species of interest, which are most common in clinical 
laboratories because they ensure elimination of the sensor interference. However, this 
may be difficult to integrate into POC sensors because specialized equipment and 
personnel are typically required, and separation may affect other properties (including 
the analyte) of the sample. For these practical reasons, employment of materials at the 
sensor surface to manipulate molecular interactions is a more typical approach in the 
design of POC sensors. This approach imparts some level of selectivity to the sensor, 
and these types of sensors are referred to as semi-selective in contrast to selective 
sensors which contain recognition elements with high levels of selectivity. 
Nonetheless, this approach suffers because molecular interactions can affect a variety 
of sample components as well as the analyte. For example, using a material coating 
that attracts the positive charge of an analyte will presumably repel negatively 
charged species, however, it will also attract other positively charged species in the 
complex sample. Due to the large number of species present in complex samples, it 




while the signal processing approach does not affect the sample since it is an end-
point technique, it may require a large number of samples and it has the potential to 
introduce computational artifacts. In all the cases, knowledge of the major interfering 
species affecting a particular sensor enables the design of a targeted approach to 
reduce the effect of those species. Without this knowledge or if only general 
information is known (i.e., the species known to interfere in other sensors), trial and 
error methods and preliminary assumptions must be employed. The latter is time 
consuming and has the potential for missing interfering species that are particular for 
the individual sensor. 
 
1.2.2 Therapeutic Drug Monitoring: Clozapine 
TDM refers to the quantification of serum or plasma concentrations of medications 
for use in dose optimization and tailoring [17, 18]. Measurement of drug 
concentration has only been proven helpful in circumstances where drug adherence is 
uncertain, there is a narrow therapeutic range, there is no response of therapeutic 
dosage, or pharmacokinetic drug-drug interaction is typical [2, 17]. TDM is based on 
the assumption that plasma concentrations correlates to clinical effects and has a 
therapeutic window of maximal safety and efficacy. The lower therapeutic limit 
corresponds to the concentration under which therapeutic response is unlikely, and 






In psychiatry, TDM can be useful due to the variability in inter-individual treatment 
response. The 2011 published guidelines for TDM in psychiatry rated 128 
neuropsychiatric drugs according to the usefulness and recommendation for TDM 
[17]. According to these guidelines, TDM is especially necessary for drugs with 
narrow therapeutic ranges, where close monitoring can guide drug titration after the 
initial prescription of after dose changes. Currently, TDM has become routine for a 
considerable number of psychopharmacologic compounds with clear evidence of its 
benefits. For instance, TDM has become the standard of care for lithium as well as 
CLZ treatment due to their narrow therapeutic range. However, regular monitoring of 
these medications can be burdensome for patients and doctors. For this reason, 
technologies capable of monitoring therapeutic concentrations of these medications in 
real-time and at the POC would aid in treatment management.  
 
Lithium and CLZ are important neuropsychiatric medications because they are 
effective for treatment resistant unipolar depression and schizophrenia, respectively. 
Lithium is a mood stabilizer with a therapeutic range of 4 – 8 µg/mL (0.4 – 1.2 mM). 
FDA-approved POC devices for lithium TDM exist in the commercial sector, such as 
the colorimetric ReliaLAB instrument.  This instrument consists of a blood separator 
membrane to separate plasma from blood, which is added to a prefilled cuvette 
containing a colorimetric agent and placed in a photometric reader [19]. Clozapine 
(CLZ) is the most effective antipsychotic treatment-resistant schizophrenia with a 
therapeutic range of 0.35 – 1 µg/mL (1 – 3 µM) [2, 17, 20]. CLZ blood monitoring, 




POC CLZ TDM exists in the market. Our research group at UMD, in a collaborative 
effort with Dr. Deanna Kelly at the Maryland Psychiatric Research Center (UMB) 
and Dr. Gregory Payne at UMD, has been working towards developing a POC 
solution for CLZ TDM using microsystem technology for the past 3 years. Our 
research aims to monitor the CLZ treatment [21] as well as white blood cells (WBCs) 
[22], whose measurement is recommended for monitoring agranulocytosis, a primary 
side effect of CLZ treatment. As shown in Figure 3, the aim is to integrate both 
monitoring technologies such that a point-of-care solution can be developed, which 
has the potential to decrease the burden of CLZ treatment monitoring and increase 
efficacy of this treatment [21-23]. Moreover, these technologies represent model 
systems for integrate POC diagnostic and prognostic devices. 
 
 
Figure 3. Closing the loop with microsystems technologies. The big loop shows the number of stages 
and amount of personnel needed for monitoring blood levels in current practice, which represents a 
burden for the patients and the doctors. The smaller loop represents the convenience of POC solutions 
(such as the CLZ and the WBC monitors developed in our group [21, 22]), which can decrease the 
burden and increase the efficiency of CLZ management. These microsystems are amenable to wireless 





1.2.3 Bioelectrochemical Sensing 
1.2.3.1 Overview  
Bioelectrochemical methods refer to the measurement of electrical properties of a 
biological system for extracting information. Electrochemical techniques are rapid 
and have been successfully applied to trace measurements due to their high sensitivity 
and selectivity [24]. Analytes in solution can be measured by applying electrical 
energy (i.e., current or voltage) through electrodes and measuring the electrical 
response. The three major methods can be divided according to the type of electrical 
signal that is applied and measured: potentiometry (constant current is applied as the 
potential is measured), coulometry (constant potential is applies as the current is 
measured), and voltammetry (altering potential is applied as the current is measured). 
While potentiometry and coulometry are ideal for systems where interference from 
other sample components is avoidable, voltammetry can provide additional 
distinguishing parameters for separating the potential response signals of various 
species.  
 
Voltammetric responses contain two major components that represent the 
electroactive species and its concentration: the oxidation or reduction peak potential 
(Ep) which is a compound-specific value correlating to the ability of a species to 
donate electrons at a particular energy, and the oxidation or reduction peak current 
(Ip) which correlates to the species concentration [24]. Thus, voltammetry has a grade 
of selectivity that depends applied potential range and the number of species that are 




occur if the reaction proceeds, providing more patterns to differentiate the analyte of 
interest [24]. 
 
Interference and electrode fouling are two major problems of electrochemical sensors 
[9], as discussed in section 1.2.1.2. For instance, if the applied potential required to 
oxidize or reduce the analyte of interest can also oxidize other species present in the 
sample, this will result in a response that overestimates the analyte concentration and 
cause peak overlap of their individual responses [14].  
 
1.2.3.2 Electrode Materials  
Advances in material science and nanotechnology have led to the development of a 
wide variety of electrode material coatings that serve as highly sensitive and semi-
selective materials in a sensor.  Carbon based materials have lower background 
oxidation currents compared to metal electrodes. Carbon nanotubes, for instance, can 
be coated on electrodes to create high surface areas with fast electron transfer 
kinetics, which increases the sensitivity and decreases the potential required for redox 
reactions [25, 26]. The increased resolution of electrochemical peaks can provide the 
ability to better differentiate current responses of species with similar peak potentials. 
Similarly, nanoparticle-modified electrodes have been shown to confer catalytic 
activity and may change electrode kinetics and reaction mechanisms due to the 
changed electronic structure at the nanoscale [27]. Furthermore, electrodes may be 
chemically modified via self-assembly monolayers (SAM) or polymer film formation. 




limitations exist with the low-density monolayer coverage this technique can achieve 
[28]. Electrode modifications involving polymer coatings are also advantageous due 
to their ability to electrodeposit onto electrode surfaces to form tunable coatings that 
can be functionalized. For instance, molecularly imprinted polymers (MIPS) are 
synthetic polymers used to mimic the specific recognition of enzyme elements. MIPS 
are fabricated by spatially arranging and cross-linking monomers around template 
molecules, which are then removed such that the final product is able to rebind the 
original template molecule [29]. MIPS can be used as a recognition element in a 
biosensor or as a means for extracting low-concentration species. Another class of 
polymer coating involve conductive polymers, such as polypyrrole and polyaniline, 
which have low electrical resistivity and amplify electrochemical responses due to 
their high conductive surface areas [8, 30]. Moreover, in a recent review by our 
group, the versatility of electrode coatings made with chitosan polymers were shown 
to be deposited controllably, to direct electrochemistry of proteins, to control 
permeability, to modify nanostructures, and to act as a graft for other functional 
molecules [31]. Our collaborators Dr. Eunkyoung Kim and Dr. Gregory Payne 
demonstrated the electrochemical grafting of catechol moieties onto the chitosan film, 
creating a redox cycling system (RCS) [32, 33]. By grafting electroactive catechol 
moieties close to the surface of the electrode, the material coating was shown to 
reduce species after being oxidized at the electrode such that a cycle of oxidation and 
reduction is created. In that manner, the RCS can amplify the electrochemical signal 
of the analyte via redox cycling by increasing the number of electrons transferred at 




its synergy with electronics and micro-scale fabrication, where sensing electrodes can 
be incorporated directly on-chip.  
 
1.2.3.3 Electrochemical Clozapine Detection 
CLZ belongs to a large class of drugs structurally defined as dibenzo-1,4-diazepines, 
which undergo reversible 2 electron/one proton redox reactions [34]. Van Leeuwen et 
al. showed the following scheme (scheme 1), where CLZ can be semi-reversibly 
oxidized and reduced. Due to the instability of reaction products, the reversibility is 
not complete because (electroactive) byproducts form after CLZ oxidation. The major 
electroactive byproduct is thought to correlate to hydroxylated CLZ derivatives and is 
also reversible [35]. Figure 4 illustrates the cyclic voltammetry response for clozapine 
at a carbon paste electrode, where oxidation and reduction peaks are seen for the 
clozapine redox reaction and similarly for the byproduct redox reaction [36]. 
 










Figure 4. Cyclic voltammetry of clozapine at a carbon paste electrode, illustrating the redox reaction. 
The larger oxidation and reduction peaks correlate to the primary clozapine reaction, and the smaller 
oxidation and reduction peaks correlate to the byproduct reaction [36]. 
 
Electrochemical CLZ sensing systems have been shown in the literature over the 
years. A vast majority of them show electrochemical analysis in buffer-based 
solutions [36-47], with a large subset demonstrating detection of CLZ in 
pharmaceutical samples for applications in quality control [37-40, 42, 43, 46, 48], and 
a minority demonstrating detection in human blood serum or plasma samples [37, 39-
41, 46]. Recently, our group published results of a micro-scale CLZ sensor based on 
chitosan-catechol redox cycling system (ccRCS) modified electrodes, in buffer and 
untreated serum samples [21].  
 
Of those sensors demonstrating detection in human serum or plasma, all contained 
pre-treatment steps that included diluting, changing the pH, and removing the 
proteins from the sample. The only exception is our ccRCS based sensor, for which 
the serum sample was not pre-treated [21]. Yet it demonstrated challenges in the 




show the application for serum-based measurements, only a minority carried out an 
interference study [37, 46]. Additionally, only a few demonstrate the raw 
electrochemical response of serum-based samples, where it is clear that an oxidative 
background signal of serum (present even in the treated samples) appears at a location 
close to that of the CLZ oxidation, and seems to be convoluted with the CLZ peak 
[21, 40, 41]. Lastly, only a partial study of interfering species has been carried out for 
CLZ sensors, and the abovementioned background peak has not been assigned to any 
particular species or effect, to the best of my knowledge. In order to achieve CLZ 
detection in human serum matrices and translate the sensor design to micro-scale 
POC devices, a design with minimal pre-treatment steps and sensor modification 
amenable to microsystem fabrication is strongly preferred. Moreover, an 
understanding of the background signals of interfering species present in the serum 
sample matrix can guide a more targeted design for a POC CLZ sensor. 
 
 1.2.4 Cross-Reactive Sensor Arrays 
 
Whereas the design of single, highly selective lock-and-key sensors have been used 
for species with specific recognition elements, a related approach uses a semi-
selective, cross-reactive sensor (CRS) that capitalizes on physicochemical effects and 
molecular interactions to impart some selectivity toward an analyte [49, 50], as 
mentioned in section 1.3.2.2. The latter approach is appropriate when a specific target 
compound is measured in controlled backgrounds or when the composition of the 
fluid matrix is known [49]. Thus, challenges and limitations arise in the case of 




backgrounds with intricate interactions exist. However, a strategy that addresses this 
challenge is the employment of CRS arrays, inspired by the biological function of the 
olfactory system in odor detection [49]. Studies have shown that each individual 
olfactory receptor is not highly specific but rather each receptor can respond to many 
analytes and it is the integrated response of a combination of receptors that enables 
identification of odors [49, 51]. Olfactory receptors are cross-reactive, meaning that 
they can be activated by a variety of odorants.  
 
The concept of employing CRS arrays for chemical detection was given the term 
“artificial or electronic noses and tongues” (depending on the phase of the sample) 
[50-54]. As illustrated in Figure 5, the combination of olfactory receptors activated by 
the coffee odorant sends a set of signals to the brain, which processes the information 
and matches it to a database of odors in order to identify the smell. Similarly, the 
coffee odorant generates a response from a combination of CRS in the artificial nose 
system, whose signal is processed by a pattern recognition model (i.e., commonly 
chemometrics) and is compared to a previously obtained database in order to identify 
the smell. In this way, the artificial nose/tongue concept mimics the processes for 






Figure 5. The schematic shows the order of events of how coffee is sensed. The smell of coffee binds 
to a series of olfactory receptors, which send signals to the brain, which interprets the receptor 
sequence to interpret the source of the smell. Similarly, the smell of coffee binds differentially to a 
series of sensors in an array, whose response is analyzed by a chemometric data processing model, 
which matches the pattern with a database to interpret the odor. 
 
 
The advantage of utilizing an artificial tongue approach is the ability to yield 
responses for a variety of analytes, including those for which the sensor was not 
originally designed to detect. The array integrates the responses of a variety of 
components of the complex matrix such that a unique pattern for the complex 
solution is generated without the requirement of prior knowledge of individual 
components. Such arrays should be designed such that the sensors are cross-reactive 
to the diversity of analytes and their concentrations in the sample. CRS refer to 
receptors that are generalized rather than specialized. Thus, receptors need not be 
designed to target specific analytes but rather need to be designed to be differential, 
such that added and synergistic patterns are provided by additional sensors in the 
array [50]. Additionally, CRS should provide diversified responses such that each 
additional sensor provides additional information. For instance, an additional sensor 
may be cross-reactive to other components of the sample or may provide an 
orthogonal measurement of the same compounds. Electrochemical sensors utilized for 




polymeric [54, 56, 58-63] and chemical [64] electrode modifications, or electrode 
materials [52, 53]. 
 
By relying on patterns of the multi-sensor response, the sensor system reduces the 
need for selectivity [49]. In order to realize the full-potential of CRS arrays, signal 
processing methods are employed to integrate the multivariate response patterns 
across the array. Common signal processing algorithms used in artificial tongues are 
chemometric techniques, which are numerical techniques that extract useful 
information from chemical systems [65].  Quantitative or qualitative models can be 
applied to obtain either presence/absence information or concentration values [66]. 
Moreover, advanced models such as artificial neural networks are capable of being 
trained to a certain sample matrix, such as the particular baseline signal of an 
individual’s serum, and can account for the sample matrix changes that may differ 
from person to person [67]. Thus, the diversity of a sensor array provides 
multidimensional information that can account for variable interfering species in 
blood. One can account for known interferents within the algorithm, and some papers 
have gone as far as to show how they are capable of de-convoluting conflicting 
response peaks [68-70]. Common chemometric algorithms include principal 
component analysis (PCA), partial least squares regression (PLS) and artificial neural 
networks (ANN). Some examples of sensing techniques and corresponding 
chemometric models used for quantitative determination of various biological 












PCR, PLS [71] 








2 hormones: ethinylestradiol, levonorgestrel Spectrophotometric PLS, PCR [72] 
Anti-inflammatory drugs: indomethacin, 





Heart medications: Furosemide, amiloride 
hydrochloride 
Spectrophotometric PLS [68] 
Table 1. Summary of chemometric models applied to multi-analyte determination 
 
1.3 Thesis Contributions 
A chitosan-catechol electrode material coating was tested for its performance in the 
presence of a common interfering species as well as in the complex serum matrix. In 
parallel, a systematic methodology incorporating the use of cross-reactive sensors 
was developed in order to explore and identify interfering species in serum-based 
sensing. This thesis presents a method for screening, discerning and matching 
individual interfering species in buffer and serum matrices. The feasibility of this 
approach was demonstrated using the model analyte, CLZ with the following specific 
contributions: 
a) The selectivity of the chitosan-catechol modified sensor was evaluated. 
b) Species present in blood serum were screened using electrochemical 
methods and tested for statistical significance in order to narrow down 




c) A set of cross-reactive sensors were characterized to investigate the 
functionality and ability of each sensor to sense a variety of species and 
provide diversified responses. 
d) The performance of the cross-reactive sensors in providing insight into the 
effect of interfering species in the CLZ measurement. 
e) Application of multi-dimensional mapping of the sensor responses to 
create patterns that enabled matching of signals from CLZ and interfering 




Chapter 2: Chitosan-Catechol Redox-Cycling System  
 
2.1 Design 
 2.1.1 Implementation of the Chitosan-Catechol Coating 
Chitosan is a polysaccharide that is capable of being controllably electrodeposited 
onto electrode surfaces by the application of potential energy, to form a hydrogel 
film. The use of chitosan is advantageous because it can serve as a graft for additional 
functional elements. For instance, it enables grafting of catechol moieties close to the 
electrode surface, as shown by Kim et al. [73], which in turn can be used for redox 
cycling. Redox cycling refers to a type of catalytic behavior, where an 
electrochemically reversible species can be cycled through a continuous process of 
oxidation and reduction. By engineering an RCS whereby a species of interest can be 
continually oxidized by an applied electrode potential and reduced by catechol 
moieties close to the electrode surface, signal amplification can be achieved via redox 
cycling.  Thus, the ccRCS is amenable as a signal amplification technique for CLZ 
sensing.  
 
Redox cycling will occur between the electrode and the catechol moieties if the 
analyte is an oxidizing mediator with a redox potential that is larger than that of 
catechol (~0.2 V). Thus, CLZ, which has a redox potential of ~0.4 V, is a good 
candidate for redox cycling amplification by the ccRCS film.  Toward the application 




where an electron cascade follows the path of thermodynamic favorability (least 
resistance). A reducing mediator (hexaammineruthenium; Ru) with an oxidation 
potential of -0.2 V, can charge the chitosan-catechol film by donating electrons to it. 
When negative potentials are applied, Ru is reduced so that this source of electrons 
for the chitosan-catechol film is continuously regenerated during measurement. When 
positive potentials are applied, CLZ can be oxidized at the electrode. CLZ can then be 
reduced back to its original state by reacting with the grafted catechol moieties, such 
that re-oxidation at the electrode occurs. The continuous redox reaction of CLZ 
between the electrode and the catechol moieties can increase the total charge 
transferred by CLZ oxidation, amplifying the generated electrochemical current and 
improving the signal-to-noise ratio. 
 
 
Figure 6. Hypothesized Electrochemical Scheme at ccRCS Electrodes. (A) Scheme illustrating the 
CLZ electrochemical redox at the RCS. CLZ is thought to undergo redox cycling due to the ability of 
catechol in the RCS to reduce CLZ and enable repeated CLZ oxidation at the electrode. (B) Electron 





 2.1.2 Previous Work 
We have previously demonstrated the use of the ccRCS for CLZ measurement in 
buffer-based solutions, as shown in Figure 7. In the optimized system, a sensitivity of 
54 ± 7 (µC/cm
2
)/(µL/mL) and 7.0 ± 2.6 (µC/cm
2
)/(µL/mL) for catechol-chitosan and 
bare electrodes, respectively, was achieved. Thus, higher sensitivity values were 
achieved with the ccRCS, suggesting increased peak current generated by redox 
cycling of CLZ at the ccRCS (Figure 7b). Preliminary serum-based CLZ 
measurement show the responses near the therapeutically relevant CLZ 
concentrations although with higher limits of detection and error compared to buffer-
based solutions (Figure 7c). However, signals from the CLZ-spiked serum 
demonstrate lower performance and require subtraction of the un-spiked serum 
background signal in order to be resolved. This is not ideal in practice since 
information about a subject’s blood sample without the medication is not typically 
available. Nonetheless, it demonstrates a first step toward sensing in serum without 







Figure 7. Calibration of CLZ at ccRCS Electrodes. (a) Cyclic voltammogram response divided into 4 
sections, Qr_red (red-yellow) for cathodic charge at E < 0 V (Ru reduction), Qr_ox (blue) for anodic 
charge at E < 0 V, Qo_ox (purple) for anodic charge at E > 0 V (CLZ oxidation), and Qo_red (green) for 
cathodic charge at E > 0 V. The Qo_ox section was correlated to CLZ concentration in (b) buffer 
solutions using bare and catechol-chitosan modified electrodes, as well as in (c) serum solutions using 






 2.1.3 Interference Studies with the Chitosan-Catechol Redox Cycling System 
Because CLZ does not have specific biological recognition elements that can be 
employed to provide selectivity to the assay, interference from other species present 
in blood serum becomes a critical factor affecting sensor performance. In order to 
achieve a lower limit of detection of CLZ in serum samples (that covers the entire 
range of therapeutic CLZ levels) as well as a more sensitive and reliable 
measurement, the fundamental properties of serum and how they affect the CLZ 
sensor will be further studied. First, semi-selectivity properties of the ccRCS are 
studied with a model interfering species (IS), ascorbate (AA) [75], which commonly 
interferes with electrochemical sensors [13, 14]. Then, a closer examination of the 
serum responses at the ccRCS was used to assess this material coating with regards to 
interference.  
 
Even though the ccRCS electrode modification does not provide the selectivity that 
biological recognition elements possess, it has intrinsic properties that can minimize 
the effect of interference. Specifically, only species whose oxidation potentials fall 
between that of catechol (0.2 V) and that of the applied electrode potential can 
thermodynamically receive electrons from catechol and thus be amplified by 
oxidative redox cycling. For instance, CLZ, which has an oxidation potential larger 
than 0.2 V, is shown to undergo redox cycling whereas AA, which has an oxidation 
potential below 0.2 V, is hypothesized to be unable to receive electrons from the 
catechol moieties (as illustrated in Figure 8). Furthermore, the ccRCS can only 




Electrochemically irreversible or unstable species (such as AA) would be unable to be 
reduced and re-oxidized in a redox cycling manner. These properties of the ccRCS 
enable what we refer to as semi-selectivity of the sensor. 
 
 
Figure 8. Scheme illustrating the hypothesis for (a) CLZ and (b) AA electrochemical redox at the 
ccRCS. CLZ is thought to undergo redox cycling due to the ability of catechol in the ccRCS to reduce 
CLZ and enable repeated CLZ oxidation at the electrode. AA is thought no to undergo redox cycling, 
likely due to its instability and irreversibility as well as the lack of energetic favorability for redox 
cycling with catechol in the ccRCS. 
 
2.2 Methods 
 2.2.1 Electrochemical Cell 
Electrochemical tests are carried out in a three electrode cell configuration, unless 
otherwise stated, using a CHI660D potentiostat (CH Instruments; Austin, TX). The 
three-electrode cell, illustrated in Figure 9, consists of a 2 mm diameter gold working 
electrode (CH Instruments; CHI101), a platinum foil counter electrode, and a 
Ag/AgCl reference electrode (CH Instruments; in 1 M KCl) in a closed cell with 1.6 
mL sample solution. The working electrode was polished using 0.05 micron alumina 
powder before each film fabrication in order to regenerate the surface and remove any 




validated before every test by measuring a model redox couple using a cyclic 
voltammetry technique (CV: initial and final potential: 0.19 V, potential range: -0.06 
V to 0.44 V, scan rate: 0.2 V/s, 6 cycles), and comparing it to previous CV responses. 
The redox couple solution consisted of 10 mM phosphate saline buffer (PBS), 100 
mM sodium chloride, 10 mM ferricyanide and 10 mM ferrocyanide. The typical 
ferrocyanide/ferricyanide CV response is shown in Figure 10a. When responses not 
consistent with previous ones occur, the electrode surface is polished again until the 





 2.2.2 Chitosan-Catechol Film Fabrication 
Film fabrication consists of two consecutive steps: chitosan electrodeposition and 
catechol grafting. Chitosan (1% solution in dilute HCl; pH 5-6) was electrodeposited 
on the working electrodes by applying a constant cathodic current of 6 A/m
2
 for 45 
seconds on the working electrode, followed by rinsing with phosphate buffer saline 
Figure 9. Electrochemical cell composed of a gold working electrode, Ag/AgCl reference electrode, 




(10 mM PBS; pH 7) solution to form a clear hydrogel around the electrode. Next, 
catechol (5 mM solution in 0.1M phosphate buffer (PB; pH 7.0)) was grafted onto the 
chitosan film by applying a constant positive potential of 0.6 V for 3 minutes, 
followed by immersion in water for 5 minutes to discard unbound catechol. This 
process forms chemical bonds between the chitosan film and the catechol moieties. 
The electrochemical responses of the chitosan electrodeposition and catechol grafting 
are shown in Figure 10b and c, respectively. A new film was generated for each 
sensing measurement.  
 
 2.2.3 Electrochemical Validation 
Following film fabrication, another validation step was employed to ensure minimal 
between-electrode variability. The validation tests employed a CV (initial and final 
potential: 0 V, potential range: -0.4 V to 0.7 V, scan rate: 0.1 V/s, 7 cycles) using a 
solution of 25 μM 1,1’- ferrocenedimethanol (Fc) and 25 μM hexaammineruthenium 
(III) (Ru) in 0.1 M PB (pH 7.0) solution. Fc serves as an oxidizing mediator which 
discharges the ccRCS film, and Ru serves as a reducing mediator which charges the 
film. When the redox response matches the Fc/Ru response from previous ccRCS 
modified electrodes (Figure 10d), it can be assumed that the film properties are similar 







2.2.4 Electrochemical Clozapine Measurement in Buffer 
Electrochemical testing was performed with solutions of 25 μM CLZ, 25 μM Ru, and  
100 μM ascorbic acid (AA) in 0.1 M PB (pH 7) using a cyclic voltammetry (CV) 
technique (initial and final potential= 0 V, potential range: -0.4 V to 0.7 V, negative 
initial scan polarity, scan rate = 0.01 V/s, 7 sweep segments, sample interval 0.001 
Figure 10. Electrochemical responses of the fabrication and validation steps for chitosan-catechol 
electrode modification: (a) cyclic voltammogram for Ferrocyanide/Ferricyanide redox species used for 
validating regeneration of the electrode surface after polishing, (b) chronopotentiometry for chitosan 
electrodeposition, (c) chronoamperometry for catechol grafting, and (d) cyclic voltammogram for Fc/Ru 
chitosan-catechol film validation (last cycle shown). The gold-colored surface in the inset illustrations 
represents the commercial gold electrode, the transparent gray-colored rectangle represents the chitosan 




V). All samples were purged (bubbled) with nitrogen gas for 10 minutes before 
electrochemical measurements to remove dissolved oxygen. This step is important in 
the characterization stage because it ensures less background noise in the CVs 
response. Data was processed by subtracting the 0.1 M PB background signal 
obtained with bare gold electrodes from each sample response and the last CV cycle 
is shown. 
 
 2.2.5 Electrochemical Clozapine Measurement in Serum 
Commercial human blood serum (from human male AB plasma, USA origin, sterile-
filtered, Sigma Aldrich) was divided into 1 mL aliquots and stored in -20 °C 
conditions. Prior to the experiment, the serum was thawed at room temperature. 
Commercial undiluted serum was spiked with 25 µM Ru and 10 µM CLZ 
concentrations immediately before testing.  
 
The CLZ-spiked serum samples were tested using a lab-on-a-chip platform [74]. 
Briefly, an on-chip electrochemical cell containing a gold working electrode (WE; 
disk-shaped, 1.5 mm radius), a gold counter electrode (CE), and a reference Ag/AgCl 
reference electrode (RE) was defined by a patterned photoresist, resulting in a 
chamber with 4.5 mm radius and height of 22 µm. The on-chip open Ag/AgCl RE is 
fabricated by a 2-step electrodeposition method: 1) Ag electroplating on the patterned 
Au electrode, 2) AgCl generation on the Ag electrode surface [76]. The 




0 V, potential range: -0.4 V to 0.6 V, scan rate: 0.02 V/s, 1.5 cycles). All 
electrochemical tests were done in duplicates and the average is shown. 
 
2.3 Experimental Results  
 2.3.1 Clozapine Detection with Bare Gold Electrodes 
As seen in Figure 11, the CV response of CLZ with gold electrodes (before surface 
modification) shows a primary reversible redox reaction near 0.38 V, and a secondary 
reversible redox reaction near 0.18 V corresponding to the electroactive CLZ 
byproduct, as described in section 1.2.3.3. The four peak responses of CLZ illustrate a 
pattern with respect to peak location that is characteristic to this species. 
 
 
Figure 11. Cyclic voltammograms of 25 µM CLZ oxidizing mediator in the presence of 25 µM Ru 
reducing mediator in PB solutions (pH 7.4) using bare (no surface modifications) gold electrodes. 





 2.3.2 Clozapine Detection with Chitosan-Catechol Redox Cycling System 
The ability of the ccRCS to amplify the oxidation response of CLZ is shown in Figure 
12, in a cyclic voltammogram with a solution containing CLZ and Ru. From the 
figure, a marked increase in electrochemical current for the CLZ oxidation becomes 
immediately apparent, illustrating the amplification benefits of the ccRCS. The gain 
in signal can be quantified with an amplification factor of 9.2, derived using equation 
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The CLZ amplification observed with modified electrodes is due to the donation of 
electrons from catechol moieties to CLZ molecules. This electron transfer reduces the 
CLZ back to its original form, enabling each CLZ molecule to be oxidized multiple 
times at the electrode surface. The sustained cycling of CLZ oxidation (at the 
electrode) and reduction (at the catechol) constitutes the redox cycling of CLZ, which 
amplifies the CLZ oxidation signal. Moreover, the oxidation potential of CLZ is 
observed to shift from 0.38 V in bare electrodes 0.48 V in modified electrodes, as 
seen in Figure 12, likely due an increased uncompensated resistance from the 
physical boundary created by the chitosan film, which decreases the diffusion of CLZ 
to the electrode surface. Similarly, the Ru signal is also amplified in the ccRCS 
modified electrode since catechol oxidizes Ru as it is charged, generating more 






Figure 12. Cyclic voltammograms of 25 µM CLZ oxidizing mediator in the presence of 25 µM Ru 
reducing mediator in PB solutions (pH 7.4) using bare (no modification) and ccRCS modified gold 
electrodes, showing an amplification factor of 9.2 of CLZ with the modified system. 
 
2.3.3 Interference Study with Ascorbate 
The electrochemical behavior of AA (100 µM) and CLZ (25 µM), individually and 
mixed, were studied. They are first analyzed on bare electrodes to understand the 
intrinsic behavior of each species in a simple system. As shown in Figure 13, AA has 
an oxidation peak at 0.18 V, whose tail overlaps with the sharper CLZ peak at 0.38 V 
due to the broad width and the larger relative peak current of AA compared to CLZ. 
When AA and CLZ are measured simultaneously, the CLZ peak current increases 
1.8-fold compared to the response of CLZ individually. It is ambiguous whether 
ascorbic acid is amplifying the CLZ peak by donating electrons to it or interfering 
with the system due to a peak overlap. In either scenario, the CLZ signal appears to 
be dependent on the ascorbic acid response, which may be a challenge because the 






Figure 13. Cyclic voltammograms of 25 µM CLZ and 100 µM AA individually and in mixture (mix), 
in PB solutions (pH 7.4) using bare gold electrodes. The figure shows the interference from the AA on 
the CLZ oxidation peak as a change in peak amplitude. 
 
The ccRCS-modified electrodes show a significant increase in the CLZ peak response 
(AF = 9.2) for ccRCS compared to unmodified electrodes but less amplification for 
AA (AF = 1.6) in Figure 14a. In fact, whereas the response of AA was larger in the 
unmodified electrodes compared to the CLZ response, the opposite occurs for the 
ccRCS. Thus, the ccRCS indeed has the capability of semi-selective amplification of 
CLZ compared to AA. Furthermore, when CLZ and AA are simultaneously present, 
the oxidation peak current of CLZ is not significantly affected by the presence of AA. 
In the presence of AA, the CLZ peak increases only by 1.15-fold compared to the 
individual CLZ peak, compared to a 1.8-fold increase in the bare electrode. Lastly, 
when measuring the overall effect of AA in the complete ccRCS for CLZ 
measurement, where Ru film charging agent is present, no apparent difference is seen 
in the presence or absence of AA, as shown in Figure 14b. Thus, the ccRCS can 
minimize selectivity issues encountered in unmodified gold electrodes with its semi-






Figure 14. Cyclic voltammograms of (a) 25 µM CLZ and 100 µM AA individually and in mixture, in 
PB solutions (pH 7.4) using ccRCS modified gold electrodes, showing increased amplification of the 
ccRCS for CLZ compared to AA. (b) Effect of AA on the overall CLZ measurement using the ccRCS, 
when the 25 µM Ru film charging agent is present. 
 
 2.3.4 Interference Studies with Serum 
As seen in Figure 15, the CV of the background untreated serum current response 
exhibits two peaks at 0.42 V and 0.51 V. This result is extremely important because 
these background signals occur in the vicinity of the CLZ oxidation signal. Moreover, 
the addition of CLZ to blood serum led to a peak overlap with the background signal. 
An incremental increase in response compared to the background peak is observed in 
the presence of CLZ, where the background peak is dominant likely due to lower 






Figure 15. Cyclic voltammograms of untreated blood serum spiked with Ru reducing mediator, with 
and without 10 µM CLZ at the ccRCS modified elecrode. The figure shows the background peaks that 




In contrast to AA, interferences from other species in blood serum were not rectified 
by this sensor design configuration. Some suggestions for improving the sensor 
performance in blood serum include identifying the interfering species from the 
sample matrix, incorporating a sensor material that creates a barrier for the interfering 
species to the sensor surface, or employing a different type of sensor whose 
mechanism targets the differentiation of the particular interfering species in the 
sample. Nonetheless, these suggestions require knowledge of the species involved in 
the background serum signal and/or CLZ interference. 
 
2.4 Summary 
The ccRCS modified electrodes were shown to amplify CLZ electrochemically 9.2-
fold compared to unmodified electrodes. This amplification capability improves the 
signal-to-noise ratio, which can enable increased sensitivity for low-concentration 




CLZ and AA common interfering species indicated that the ccRCS did not amplify 
the AA signal, demonstrating semi-selectivity for CLZ. However, other interfering 
species in blood serum were seen to interfere with the CLZ measurement and require 
further studies. 
 
To improve the selectivity and performance of a CLZ sensor for serum measurement, 
a broader interference study would be useful to identify and account for interference 
from the numerous species simultaneously present in blood serum, especially in the 
case of semi-selective (rather than fully selective) sensors, where interfering species 
can have significant effects on the analyte measurements. This methodology can 
enable a more targeted sensor design for CLZ to account for the relevant interfering 
species, and its development is described in the next section. The results can provide 
guidelines for improving the selectivity of the ccRCS (and a broader set of sensors) in 




Chapter 3: Screening of Interfering Species in Blood Serum 
 
3.1 Design 
Some of the endogenous and exogenous species present in blood serum are redox-
active and can interfere with the CLZ measurement via cross-reactions or signal 
overlap, for instance. Due to the lack of highly selective biorecognition elements for 
CLZ and the complexity of human blood serum, a method of identifying serum 
species that interfere with the CLZ measurement was developed.  
 
The design for a systematic methodology for interference screening and 
characterization is presented. It consists of screening species present in serum 
individually by testing their electrochemical response in buffer solutions. This step 
consists of testing a carefully selected set of endogenous species with respect to their 
effect on the CLZ measurement. Assessment of the electroactivity of these species 
tested individually and in simulated mixtures (CLZ + individual species) can be used 
to characterize the effects from the simultaneous presence of multiple species in 
solution. In the next chapter, a comparison between buffer-based individual species to 
serum responses is used to match response signals of serum to individual species. By 
combining buffer-based screening with serum-based testing, we can expect to identify 
and validate endogenous serum species with significant interference to the CLZ 
measurement in serum-based solutions. Once identified, their inter-dependence can 






3.2.1 Interference Screening  
A list of potential interfering species (IS) were screened at their upper physiological 
concentrations as suggested in the CLSI EP7-A2 guidelines [77], and those that 
interfere with the CLZ measurement were further characterized. Initially, we will 
consider the following classes of species as potential IS: 1) most abundant 
metabolites [78, 79], and 2) low-molecular weight species that interfere in similar 
sensors, as shown in Table 2. The latter includes electrochemical sensors for other 
CLZ sensing schemes as well as other analytes sensed in the measured potential range 
of 0 – 0.7 V [13, 37, 80-86]. 
 
Criteria Interfering Species Upper Concentration, µM 














Uric Acid 410 
Interference 







L-Glutamic Acid 150 
L-Methionine 40 
Oxalic Acid 22 
Table 2. Chosen species and upper physiological concentrations used to screen species that interfere in 






To test the extent of interference of various endogenous species with CLZ, the 
electrochemical response of simulated mixtures (individual IS + CLZ) in PBS buffer 
based solutions were compared to that of CLZ-only solutions, and expressed as a 
differences in their electrochemical peaks. A one-way ANOVA test between the two 
sample populations was carried out for two characteristic peak values, peak current 
and peak potential. The significance threshold was chosen to be α = 0.1 for the peak 
current and α=0.01 for the peak potential since the latter has intrinsically less 
variation. Using this screening approach, species posing significant effects to the CLZ 
peak were identified. 
 
3.2.2 Electrochemical Test Setup  
A glassy carbon disk working electrode (GCE, 3 mm diameter), a platinum wire 
counter electrode, and a Ag/AgCl (1 M KCl) reference electrode were purchased 
from CH Instruments. Electrochemical tests were performed with a CHI660D 
potentiostat (CH Instruments) All potential values presented are written in reference 
to a Ag/AgCl half-cell potential. The working electrodes were cleaned by 
successively polishing with 1, 0.3, and 0.05 µm alumina powders and were 
electrochemically validated before every test. Validation was performed as in section 
2.2.3. A differential pulse voltammetry technique (DPV: initial E = 0 V, final E = 0.7 
V, increment E = 0.001V, amplitude = 0.05 V, pulse width = 0.2 s, sampling width = 
0.0167 s, pulse period = 0.5 s) was employed. All species were dissolved tested in 






3.3 Experimental Results 
Individual species were systematically screened for electroactivity at their upper 
physiological concentration. Only four components were shown to be 
electrochemically active (Table 3): uric acid (UA), L-cysteine (CySH), ascorbate 
(AA) and oxalic acid (OA). One common theme among the former three species is 
their antioxidant properties [87-89], with UA accounting for a majority of antioxidant 
capacity [90]. This result suggests that antioxidants are amenable to electrochemical 
detection and may be a source of interference in blood serum. Additionally, UA, 
CySH and OA have electrochemical peak potentials similar to that of CLZ as seen in 
Figure 16, thus their peak response is most likely to overlap or affect the CLZ 
measurement.  
 
Interfering Species p,IS (V) 
Clozapine  0.34 
Uric Acid  0.245 
Ascorbate  < 0.08 
L-Cysteine  0.347 
Oxalic Acid  ~0.36 
Table 3. Interference Screening: Part 1-Electroactivity. Electrochemical oxidation peak values ( p,IS) 
of potentially interfering species with detectable electroactivity. Triplicate tests were carried out using 







Figure 16. Differential pulse voltammetry (DPV) of 60 µM L-cysteine, 410 µM uric acid, 22 µM 
oxalic acid, and 40 µM ascorbate (pH 7.4) in PBS at the GCE. Signal response represents an average 
of triplicate measurements.  
 
 
Cross-reactivity between these endogenous species and the CLZ exogenous species 
was screened. The electrochemical signals from simulated mixtures (individual 
endogenous species + CLZ) and CLZ-only solutions in buffer were compared to 
assess the effect of the simultaneous presence of the two components on the CLZ 
response. The cross-reactivity is represented in terms of the signal difference of the 
mixture and the CLZ-only solution (bias) as well as the corresponding p-values 
obtained from a one-way ANOVA test between the two samples (as described in 
section 3.3.1). As seen in Table 4, UA and CySH were found to have significant 
cross-reactivity with CLZ with respect to both peak current and peak potential (p-

























D-Glucose -0.07423 0.1858 -0.0037 0.2505 
Urea -0.0699 0.3135 -0.0047 0.0325 
ATP -0.0206 0.7888 -0.0030 0.4557 
DL-
Glyceraldehyde 
-0.0571 0.5287 -0.0003 0.9465 
L-Lactic Acid -0.0832 0.1443 -0.0030 0.4103 
L-Glutamine -0.0362 0.4611 -0.0037 0.2913 
L-Alanine -0.0574 0.3265 -0.0037 0.0254 
Glycine -0.0680 0.2230 -0.0040 0.0705 
L-Lysine 0.0661 0.1224 -0.0020 0.1447 









Ascorbate -0.0111 0.8571 0.0007 0.8309 
L-Cysteine -0.3175 0.0068 -0.0487 2.09*10
-5 
L-Valine 0.0120 0.8406 0.0023 0.2564 
L-Arginine -0.1052 0.1357 -0.0053 0.3671 
L-Glutamic Acid -0.0139 0.7502 0.0013 0.4918 
L-Methionine 0.0030 0.9520 0.0013 0.6918 
Oxalic Acid -0.0492 0.5661 0.0020 0.4885 
Ip,mix Bias = - , where  represent the mean peak current of CLZ or 
Mixture (CLZ + interfering species) of the triplicate results. 
Ep,mix Bias = , where  represent the mean peak potential of CLZ or 
Mixture (CLZ + interfering species) of the triplicate results. 
* Note: the corresponding CLZ peak in the mixture was determined as the detectable peak closest to 
the individual CLZ peak. The p-value refers to the results of an ANOVA test between clozapine alone 
and in mixture. 
 
Table 4. Interference Screening: Part 2. Statistical analysis of interference imparted on the clozapine 
measurement by interfering species. Triplicate tests were carried out using a bare glassy carbon 
working electrode in buffer-based solutions (pH 7.4). The average values are shown.   
 
3.4 Summary 
A systematic selection and coarse screening methodology was applied for identifying 
species that are present in blood serum which affect the electrochemical CLZ 
measurement. The method consisted of first selecting species with highest abundance 




which enabled narrowing down from hundreds of species present in blood serum to 
17. Then, electrochemical tests were carried out with and without the presence of 
each individual species, and only 2 species were identified for interference with the 
CLZ measurements: UA and CySH. Having narrowed down the interfering species, 
studies in Chapter 4 are focused on the interaction of UA and CySH with CLZ and 









4.1 Design of Cross-Reactive Sensors 
4.1.1 Overview 
Sensor arrays have been used as part of a concept known as the artificial tongue and 
nose to enable multi-analyte assessment in complex mixtures by coupling it with 
signal processing (i.e., chemometric) models, as discussed in section 1.2.4. 
Furthermore, many articles have demonstrated the ability of such systems to resolve 
overlapping peaks and account for multiple analytes (i.e., significant interferences) in 
complex fluids. This method relies on a series of CRSs that each provides diverse and 
synergistic information regarding the analyte(s) of interest. Thus, the diversity of a 
sensor array provides a multi-dimensional perspective that accounts for variable 
background and interfering signal responses in blood. However, knowledge of the 
major causes of background variability and interference in the sample allows for more 
efficiently calibrating the sensor system and chemometric models. 
 
A set of cross reactive sensors that have the capability of providing orthogonal multi-
dimensional responses to create an electronic tongue type sensor is proposed. The 
CRSs were designed to be amenable to miniaturization and provide differential signal 
responses. It consists of variations in the sensing method, such as electrical input, pH 
and material, as specified in Table 5. Each sensing method was designed to provide 




species. Signatures across the array could be represented in the form of integrated 
multi-dimensional plots that map the overall signature of the sensor array and 
facilitate comparison between samples. Further description of the choice of each 









A GCE DPV 7.4 
B GCE DPV 6.5 
C GCE DPV 8.0 
D GCE CV, oxidation, cycle 1 7.4 
ΔD GCE 
CV, oxidation, difference 
between cycles 
7.4 
E GCE CV, reduction, cycle 1 7.4 
F Pt DPV 7.4 
Table 5. Experimental conditions for the CRS set, with elements A-F used to generate various sensor 
responses. GCE refers to glassy carbon electrodes, Pt to platinum electrodes, DPV refers to differential 
pulse voltammetry and CV refers to cyclic voltammetry. 
 
4.1.2 Electrochemical Techniques 
Differential pulse voltammetry (DPV) is an electrochemical technique with superior 
resolution of its peak signal. DPV consists of applying a linear potential ramp (dE/dt) 
superimposed with a series of constant pulses. ∆𝐸 is the difference of the pulse and 
the baseline. Current is taken twice per pulse, before the start and at the end of the 
pulse, and the difference is measured. This pulsed electrochemical method minimizes 
the effect of non-faradaic (i.e., electrode surface charging) current on the signal 
output, such that a clean background signal independent of the electrochemical sweep 
history is achieved. The peak current response Ip (A) from the DPV technique is 
directly proportional to the analyte concentration Canalyte (mol/cm
3
) and pulse 
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RT t
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where n is the number of electrons exchanged, F is the Faraday constant (96487 
C/mol), A is the electrode surface area (cm
2
), R is the gas constant (8.314 J/K*mol), T 
is the temperature (K), D is the solute diffusion coefficient (cm
2
/s), and t is the time 
between pulses (s) [91].  
 
The cyclic voltammetry (CV) electrochemical method can provide additional 
information to the DPV technique. CV is the most common technique for studying 
dynamic electrochemistry, and is useful for discerning kinetics, rates and reaction 
mechanisms [91]. CV consists of a (non-pulsing) linear potential sweep performed in 
cycles spanning the anodic and cathodic potential directions at a scan rate of v. Thus, 
the CV shows oxidation as well as reduction responses, the added information 
regarding reduction reactions. If peaks of similar shape are seen in both cathodic and 
anodic directions of the CV, a species is considered reversible. Various levels of 
reversibility can occur, such as fully reversible (i.e., ferrocyanide/ferrocyanide redox 
couple) and semi-reversible reactions (i.e., CLZ), where some of the oxidized species 
cannot be reduced back again. Additionally, multiple CV cycles allow dynamic 
visualization of byproducts formed over time, which provide an additional signature 
that can be related to degradation and side-reactions of the analyte. Dynamic 
information such as the rate of change of the current response over cycling (element 
ΔD) are taken into account as well as the magnitude of the peak current Ip (A), which 
depends on bulk analyte concentration Canalyte (mol/cm
3
) and scan rate v (V/s), 
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where n is the number of electrons exchanged, F is the Faraday constant (96487 
C/mol), A is the electrode surface area (cm
2
), R is the gas constant (8.314 J/K*mol), T 
is the temperature (K), and D is the solute diffusion coefficient (cm
2
/s) [91].  
 
4.1.3 pH Adjustment 
Because the solution pH can affect the oxidation peak potential of the species in 
solution, pH was chosen as a parameter that may be able to generate differential 
electrochemical signals. The Ep (V) dependence is a function of the pH and the 
specific potential of the species at standard conditions E
o
 (V) according to the Nernst 
equation:  
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), temperature T (K), the ratio of protons m to 
electrons n transferred during the redox reaction, and Faraday constant F (C mol
-1
). 
The Nernst equation (equation 4) assumes a reversible redox reaction, fast kinetics, 
involvement of protons in the redox reaction and the concentrations at the electrode 
surface to be in equilibrium with the potential. These assumptions are not completely 
met for the semi-reversible, slow reaction of CLZ but equation 4 serves as a general 
guideline. Changes of the pH can also affect pH-dependent functional groups within 
the GCE surface that can lead to differences in attraction/repulsion forces, reaction 




species solubility. Thus, by using sensing methods to account for various sample pH 
values, fitted trends can aid in defining characteristic species-specific signatures. For 
instance, because the CLZ reaction is proton-dependent, we expect its response across 
varying pH to follow the Nernst equation (equation 4) such that the peak potential of 
the response changes with pH. By fitting the CLZ responses at varying pH’s to the 
Nernst equation we can obtain an intercept value characteristic of the CLZ standard 
potential and a slope value corresponding to the ratio of protons to electrons involved 
in the CLZ oxidation process. It is expected that these values will differ from one 
species to the others based on their characteristic properties, such as reaction rates and 
processes. 
 
4.1.4 Electrode Material 
Previous work with artificial tongues have successfully employed CRS arrays 
combining various metals and carbon electrodes [56]. The properties of an electrode 
material can affect molecular interactions (i.e., attraction/repulsion) between the 
electrode and species being measured, which can in turn affect the selectivity of the 
sensor [92].  
 
Attraction/repulsion forces between surface structures of glassy carbon electrodes 
(GCE) and species in solution can affect reaction kinetics [93, 94]. Moreover, studies 
have shown that species containing amine groups can form carbon-nitrogen linkages 
with the GCE surface after oxidation of the amine group to the corresponding cation 




electrochemical oxidation kinetics as well as in the GCE linkage. For instance, 
tertiary amines have been found to have most facile oxidation but an undetectable 
degree of binding to the GCE, likely because of steric hindrance [96]. Furthermore, 
secondary and primary amines have the least facile oxidation but can better form 
carbon-nitrogen linkages with GCE [96]. Additionally, metallic electrode materials, 
such as Pt, undergo different surface reaction processes (adsorption, kinetics, surface 
oxidation) compared to the carbon-based GCE [97, 98]. Platinum (Pt), has been 
previously shown to provide orthogonal information in an array of several electrode 
materials [99]. 
 
4.2 Methods  
 4.2.1 Electrochemical Methods: DPV and CV 
A differential pulse voltammetry technique (DPV), as described in section 3.2.2, was 
employed for elements A – C and F of the CRS set. A cyclic voltammetry technique 
(CV: initial E and final E= 0 V, high E = 0.7 V, low E = 0 V, positive initial scan 
polarity, scan rate = 0.01 V/s, 6 sweep segments, sample interval 0.001 V) was used 
for elements D – E of the CRS set.  
 
 4.2.2 Electrode Material 
A glassy carbon disk electrode (GCE, 3 mm diameter), a platinum disk electrode (Pt, 
2 mm diameter), a platinum wire electrode, and a Ag/AgCl (1 M KCl) electrode were 




CHI660D potentiostat (CH Instruments) in a three-electrode configuration of either 
GCE or Pt as the working electrode, platinum wire as the counter electrode and 
Ag/AgCl as the reference electrode. All potential values presented are written in 
reference to a Ag/AgCl half-cell potential. The working electrodes were cleaned by 
successively polishing with 1, 0.3, and 0.05 µm alumina powders and were 
electrochemically validated before every test. Validation was performed as in section 
2.2.3. 
 
 4.2.3 pH Changes 
For elements A – C of the CRS set, the pH of PBS and serum were changed 
according to the sensing element designated value by adding 1 M HCl or 1 M NaOH 
under mixing conditions, and ensuring a pH within +/- 0.2 units. The pH was 
measured using a digital Extech Oyster pH meter, calibrated daily. 
 
 4.2.4 Multi-Dimensional Mapping using Heat Maps 
MATLAB (R2013b) was used to create heat map representations of the 
electrochemical responses, using the “imagesc” tool. Heat maps show the electrode 
potential on the x-axis and the CRS sensing elements on the y-axis, with the 
electrochemical current response amplitude shown as a color scale. This visualization 
method facilitates comparison of various samples or electrodes. All signals 
represented by heat maps were processed by taking the absolute value and mean-
centering, such that larger positive signals correlate to larger responses (whether it is 




averaged for 20 mV intervals to assemble the response into 35 groups, and this 
smoothed data is shown in the heat maps. For elements D – F, the electrochemical 
signal in the presence of analytes was subtracted by the signal of the PBS buffer 
solution in the absence of the analytes, to improve the heat map resolution. Element 
ΔD represent the difference between the first and third cycle responses of the cyclic 
voltammogram, with positive values representing an increase of the electrochemical 
current response between cycles, and negative values representing a decrease of the 
electrochemical response between cycles. 
 
A second level of simplification was employed to the heat maps such that only the 
pattern of peak locations and widths is shown. This visualization of the CRS set 
enables overlapping various signal patterns for comparison. The peak locations and 
widths were determined using the second derivative of fitted response curves. To 
determine the onset and end of a peak, the locations where the curvatures of the peak 
response change (where the second derivative changes signs) were determined in 
MATLAB. As shown in the sample response in Figure 17, the location where the 
second derivative equals zero and changes signs, which also corresponds to a zero 








 4.2.5 Interference Characterization using the CRS 
Samples of 5.6 µM CLZ alone and in mixture with individual IS from previously 
determined (chapter 3) were prepared at the concentration specified in Table 2, in 
PBS solutions. Solutions containing only the IS were also prepared in PBS as 
controls. These three solutions were characterized using all the sensing methods of 
Figure 17. Sample electrochemical response and corresponding first and second derivatives showing 




the CRS and their pattern was visualized using simplified heat map representations. 
The response patterns of each of the three samples were compared in order to 
elucidate the integrated responses of the mixtures and their characteristic patterns. All 
buffer-based tests were performed in same-day triplicates and the averages of the 
signals are shown graphically, such that larger positive signals correlate to larger 
oxidation responses.  
 
 4.2.6 Serum Characterization 
Pooled commercial human serum (from human male AB plasma, originated in the 
USA, sterile-filtered) were divided into 1.2 mL aliquots and stored in -20 °C 
conditions. The frozen serum aliquots were thawed at room temperature immediately 
before use. Centrifree Ultrafiltration Devices (#4104) were purchased from Merck 
Millipore Ltd and centrifuged with 1000 µL serum samples and at a centrifugal force 
of 2000xg for 150 minutes to remove macromolecules (>30 kg/mol), such as proteins, 
from the samples. 5.6 µM CLZ was spiked in the deproteinized serum sample just 
prior to measurement using a 10 mM concentrated stock solution with a volume up to 
1% of the total volume. The pH of serum was found to be 7.45-7.70 and ~8.54 before 
and after molecular weight filtration, respectively. Thus, the pH was adjusted 
according to Table 5 by adding the necessary volume of 1 M HCl for level 
comparison with the buffer-based samples. 
 
Deproteinized serum samples were tested with and without CLZ using the CRS in 




with simulated solutions. Deproteinized serum was chosen for this comparison 
because it more closely resembles the composition and behavior expected from the 
simulated (buffer-based) mixtures. The addition of proteins in the sample creates a 
more complex environment, where surface fouling and CLZ binding are expected in 
addition to physical interactions. For the purpose of this study, protein interactions 
with the CLZ and the sensors were not taken into account. Instead, the emphasis was 
in determining the effect of the simultaneous presence of interfering species in serum 
on the CLZ measurement. 
 
4.3 Experimental Results 
The focus of the results is the measurement of CLZ in a blood serum matrix and the 
determination of the individual species that affect the measurement. CLZ represents a 
model analyte with no known biological recognition element. The discussion 
highlights the properties of a CRS design and a methodology for identifying and 
comparing IS present in a complex biological matrix.  
 
 4.3.1 Characterization of Clozapine and Interfering Species Patterns using
 Cross-Reactive Sensors 
 
In this section, the CRS elements are characterized with CLZ and the IS, and it is 
used as an investigational tool to study the electrochemical patterns and identify 
possible modes of interference. First, the multi-dimensional pattern of CLZ is 
characterized using the CRS, by showing the individual responses of each sensing 




are used to characterize the patterns of UA and CySH IS individually to show the 
CRS elements’ ability to generate differential responses, as well as in simulated 
mixtures with CLZ to identify the type of interference. 
 
4.3.1.1 Clozapine (CLZ) 
Sensing element A shows a well-defined CLZ oxidation Ip at a potential of 336 mV 
(GCE, pH 7.4), consistent with the literature [35, 36]. In comparing sensing elements 
A – C, where the pH varies between 6.5 and 8.0, the Ip behavior (Figure 18a) shows 
an increase between the interval of pH 6.5 and 7.4 and a decrease between pH 7.4 and 
8.0, a trend similar to that seen by Huang et al [42]. This could be attributed to several 
factors. One possibility consists of changes to pH-dependent functional groups within 
the GCE surface that can lead to differences in attraction/repulsion forces, reaction 
kinetics or reaction mechanisms. An additional factor is the effect of pH on the 
solubility of CLZ, which is least soluble in basic pH and could have an effect on the 
electrochemical response of CLZ at pH 8.0 (element C). Notably, the peak response 






Figure 18. The CRS responses of 5.6 µM CLZ in PBS are shown across the various sensing element. 
(A) CLZ DPV signals at pH 6.5, 7.4 and 8.0 (elements A – C) using a GCE, (B) CLZ CV signal at pH 
7.4 using GCE for cycles 1 – 3 (elements D – E), and (C) CLZ DPV signal with the Pt electrode 
(element F) is compared to background reactions of PBS at pH 7.4. The A – F annotations refer to the 
various elements in the CRS (Table 5). Each curve represents the average of triplicate measurements. 
 
The behavior of the pH versus Ep follows a linear equation with a slope of 48 mV/pH 
and intercept value of 682 mV, as shown in Table 6. This behavior following Nernst 
equation demonstrates the pH dependence of the CLZ oxidation reaction. The slope 
value represents the ratio of protons to electrons consumed in the CLZ oxidation 
process and the intercept represents the potential of the CLZ reaction at standard 













Individual  Clozapine 336 48 682 0.987 
Species  Uric Acid 245 46 579 0.984 
in PBS L-Cysteine 347 141 1400 0.987 
Mixtures  Uric Acid+Clozapine 245 47 592 0.997 
in PBS L-Cysteine+Clozapine 284 59 723 0.982 






  , equation 4), where slope values correspond to the ratio of protons to 
electrons consumed in the oxidation reactions and the intercept
o
E  is an estimate of the oxidation 





Sensing elements D – E show the CLZ response when using a CV measurement 
technique. Figure 18b shows the oxidation and reduction peaks of the CLZ cyclic 
voltammogram near 340 mV as well as the appearance of additional peaks attributed 
to oxidation and reduction of CLZ’s byproduct (as described in section 1.2.3.3) near 
170 mV. Furthermore, peak variations that occur across consecutive redox cycles 
demonstrate a decrease of the CLZ oxidation peak and an increase of the byproduct 
oxidation peak, consistent with the consumption of CLZ and generation of byproduct 
[35]. The latter demonstrates how additional patterns can be obtained from the CV 
curves by accounting for the dynamic information (difference between cycles), which 
represents the change in redox over cycles (i.e., time). 
 
Lastly, element F shows the DPV response using a Pt electrode. As shown in Figure 
18c, the Pt electrode has background peaks near 0 mV and 570 mV in the PBS 
solution. In the presence of CLZ, an additional DPV peak is seen at 330 mV, which is 
discerned from the background peaks. Due to the presence of background peaks, we 
suspect that changes in the sample matrix may not only affect the CLZ peak but also 
the background reactions. Thus, the background signal is advantageous in this type of 
sensor array because it can determine changes due to environmental conditions or 
matrix effects that may not be detectable with a GCE. 
 
To facilitate comparison of patterns across the various sensing methods of the CRS 




representing the CRS patterns for the particular sample. Figure 19 illustrates a heat 
map that represents the set of CLZ CRS signals. The heat map shows the 
electrochemical current response (color scale) corresponding to the applied potential 
(x-axis), for each sensing element of the CRS (y-axis). The pattern of CLZ across the 
CRS elements, shown in Figure 19a, represents a visualization tool, which transforms 
the same electrochemical responses (from Figure 18a-c) into a convenient one-entity 
representation. Furthermore, Figure 19b represents a simplified heat map, which only 
shows the peak widths and locations across the CRS elements, which are the most 
important parameters for differentiating various species. The latter provides a more 
robust method of comparing and matching patterns across various samples. 
 
 
Figure 19. (A) Heat map representation of electrochemical responses of the CRS (elements a-f) for 5.6 
µM CLZ tested individually in PBS buffer. Each row represents a different element (A-F) from Table 
5. Black outlines represent the location of peaks in the signal. Each response represents the average 
absolute value of triplicate measurements. (B) Simplified heat map highlighting only the locations and 
peak widths corresponding to the black outlines in A. 
 
4.3.1.2 Uric Acid (UA) 
UA has a characteristic oxidation peak at 245 mV in pH 7.4 buffer (GCE, element A) 
as shown in Figure 20a. Elements A – C illustrate how UA’s peak potential shifts 




mV/pH was found to be similar to that of CLZ (48 mV/pH), elucidating that the same 
ratio of protons to electrons were involved in the oxidation reactions of UA and CLZ 
(Table 6). Nonetheless, the intercept value of 579 mV, representative of the E
o
, 
provides a distinguishable parameter between the two species. In relation to 
interference in the CLZ measurement, a lower UA response would be preferred in 
order to decrease the potential overlap of the CLZ and UA peak signals. The highest 
UA response is seen at pH 6.5 (element B) and the lowest at pH 8.0 (element C).  
 
 
Figure 20. The CRS responses of 410 µM UA in PBS are shown across the various sensing element. 
(A) UA DPV signals at pH 6.5, 7.4 and 8.0 (elements A – C) using a GCE, (B) UA CV signal at pH 
7.4 using GCE for cycles 1 – 3 (elements D – E), and (C) UA DPV signal with the Pt electrode 
(element F) is compared to background reactions of PBS at pH 7.4. The A – F annotations refer to the 
various elements in the CRS (Table 5). Each curve represents the average of triplicate measurements. 
 
When CLZ was measured in the presence of UA in PBS, the patterns obtained 
throughout the CRS were similar to those seen for UA-only solutions, as illustrated in 
the heat map in Figure 21b. For instance, element A shows a single DPV oxidation 
for the UA/CLZ mixture peak positioned at the characteristic UA location. It is 
reasonable to assume that the CLZ peak current may be masked by the UA response, 
which is 5-fold higher in amplitude than the CLZ peak response and 73-fold higher in 




trend. This finding corresponds with previous studies, where interference from high 
concentrations of UA for electrochemical CLZ measurements was reported [42]. 
 
 
Figure 21. (A) Heat map representation of electrochemical responses of the CRS (elements a-f) for 
410 µM UA tested individually. Black outlines represent the location of peaks. (B) Simplified heat 
map showing the electrochemical peak locations of 410 µM UA tested individually in mixture with 5.6 
µM CLZ, as well as control 5.6 µM CLZ tested individually for comparison, in PBS buffer. Each 
response represents the average absolute value of triplicate measurements. Each heat map contains an 
individual color scale. 
 
Sensing elements D – E show the UA response using a CV technique. The CV 
oxidation peak potential of UA is positioned at 300 mV, as seen in Figure 20b. This 
peak decreases with cycles (element ΔD), as seen by the dark blue area positioned 
near 300 mV in the heat map representation (Figure 21). This behavior suggests a 
large consumption of UA throughout cycling, likely due to the irreversible redox 
nature of this species, which is also seen by the lack of reduction peaks in element E. 
Interestingly, in the presence of CLZ, the CV reduction peak of CLZ was masked in 
the presence of UA. The masking of CLZ oxidation and reduction peaks suggest that 
UA may be preventing CLZ reduction at the electrode surface, which may be caused 
UA’s potent antioxidant activity. Another suggestion may be the formation of 




concentration secondary amines in UA, which can foul the electrode surface and thus 
decrease the current response of CLZ after UA is oxidized [95, 96]. 
 
Lastly, element F shows the response of UA using a Pt electrode. As seen in Figure 
20c, UA shows a drastic shift of 180 mV in its Ep position, compared to the GCE, at 
the Pt electrode. Because CLZ did not show similar Ep shifting behavior, the relative 
Ep position of CLZ to UA can act as a parameter that varies depending on the 
electrode material. This can provide an additional characteristic signal for the CLZ 
pattern in the presence UA. Nonetheless, the larger width of the UA signal at the Pt 
electrode (compared to the GCE) overlaps with the position of the CLZ peak. In 
simulated mixtures solutions containing CLZ and UA, only one peak potential is 
seen, as shown in Figure 21b (element F).  
 
Even when the CLZ peak appears to be masked by the upper UA concentration in the 
simulated mixtures, (serum) complex samples may have different integrated 
responses in the simultaneous presence of other species. This is further studied in 
section 4.3.2. 
 
4.3.1.3 L-Cysteine (CySH) 
CySH has a wide characteristic oxidation peak at 347 mV in pH 7.4 buffer (GCE, 
element A) as shown in Figure 22a. This peak is suggested to correspond to a 2-step 
reaction of CySH’s thiol group, which yields CyS
-1
 and subsequently disulfide CyS-




disulfide bond formation between polypeptide chains during protein folding processes 
in the body, where CySH serves a critical role [100]. Elements A – C illustrate how 
the peak potential shifts with varying pH. Upon fitting to the Nernst equation (Table 
6), a slope value of 141 mV/pH and an intercept of 1400 mV differed from those 
found for CLZ or UA. This suggests characteristic differences in electrochemical 
processes among these species, with much higher proton to electron ratio and E
o
 
values for CySH. Additionally, large differences in the Ip values of CySH were seen 
across varying pH, with a distinguishable wide peak observed at neutral pH, which 
decreases at pH 8.0 and becomes ill-defined at pH 6.5. Since CLZ has an Ep position 
similar to that of CySH, the least amount of overlap between the CLZ and CySH 





As can be seen in Figure 23, the response of the CLZ/CySH simulated mixture in pH 
7.4 buffer (GCE, element A) contains one major peak near 284 mV, with a 0.62-fold 
change in Ip compared to that of CLZ individually. In parallel, an additional smaller 
Figure 22. The CRS responses of 60 µM CySH in PBS are shown across the various sensing element. 
(A) CySH DPV signals at pH 6.5, 7.4 and 8.0 (elements A – C) using a GCE, (B) CySH CV signal at 
pH 7.4 using GCE for cycles 1 – 3 (elements D – E), and (C) CySH DPV signal with the Pt electrode 
(element F) is compared to background reactions of PBS at pH 7.4. The A – F annotations refer to the 





peak near 472 mV appears in the response of the simulated mixture. Since this peak is 
not observed in either CLZ or CySH individual responses, a cross-reaction between 
these two components is likely, which can also explain the shifted Ep and decreased 
Ip. Corroborating this suggestion, Van Leeuwen et al. showed that the CySH-
containing glutathione species can react with activated CLZ to form CyS-CLZ 
adducts, which are electroactive at higher potentials [35]. Thus, the latter peak shown 
at 472 mV may be the electroactive product of the Cys-CLZ cross-reaction. 
Moreover, the pH dependency of the major peak of the CLZ/CySH mixture near 284 
mV (at pH 7.4, GCE, element A) follows a trend with varying pH shown in Table 6, 
with a slope (59 mV/pH) and intercept (723 mV) values closer to those of CLZ (48 
mV/pH and 682 mV, respectively) than to the slope and intercept values of CySH 
(141 mV/pH and 1400 mV). Thus, this peak is likely governed by the CLZ rather 
than the CySH reaction kinetics. The additional peak near 472 mV also has a pH-
dependent slope (43 mV/pH) closely resembling that of CLZ as well.  
 
 
Figure 23. Differential pulse voltammetry (DPV) of 5.6 µM CLZ, 60 µM CySH, and their mixture in 
PBS (pH 7.4) at the glassy carbon electrode (element A). This figure demonstrates the additional peaks 






Sensing elements D – E show the CySH response using a CV technique. The CySH 
CV oxidation peak (element D) is seen as a wide peak near 480 mV (Figure 22b), 
whose magnitude decreases. This behavior together with the lack of a reduction peak 
suggests consumption of CySH at the electrode, since the oxidized species was not 
regenerated. Additionally, the increase in the Ep location with cycling suggests 
possible fouling of the electrode surface. Lastly, the reduction peak of CLZ is masked 
in the presence of CySH as seen in the heat map (element E) of Figure 24b, likely due 
to the hypothesized CLZ/CySH cross-reaction, which would increase the 
consumption of CLZ before it can be reduced back. 
 
Lastly, element F shows the response of CySH using a Pt electrode. As seen in Figure 
22c, the CySH oxidation peak at the Pt electrode is positioned close to that seen with 
GCE, with a 70 mV shift to higher Ep. Moreover, an additional peak appears near 0.15 
V, but no conclusions can be drawn about this peak since the responses between 0 
and 200 mV also correspond to background oxidation processes as seen by the PBS 
response for element F (Figure 22c). In the simulated mixture of CySH and CLZ, the 
Pt electrode illustrates a pattern that masks both CySH and CLZ peaks as seen in 




Figure 24. (A) Heat map representation of electrochemical responses of the CRS for 60 µM CySH 
tested individually. Black outlines represent the location of peaks. (C) Simplified heat map showing 
the electrochemical peak locations of 60 µM CySH tested individually in mixture with 5.6 µM CLZ, 
as well as control 5.6 µM CLZ tested individually for comparison, in PBS buffer. Each response 
represents the average absolute value of triplicate measurements. Each heat map contains an 




 4.3.2 Matching Individual Species Patterns to Complex Serum Patterns 




The electrochemical activity of un-spiked and CLZ-spiked (deproteinized) serum at 
pH 7.4 was tested with a single GCE sensor using the DPV technique, corresponding 
to element A from the CRS. Figure 25 shows the voltammograms and corresponding 
heat map representing the response of serum with and without the addition of CLZ. A 
predominant peak present in the DPV response of the serum background was 
observed at 248 mV and another smaller amplitude peak at 647 mV. Comparing these 
patterns with the corresponding buffer-based patterns, the first peak can be matched 
to the characteristic oxidation potential of UA (245 mV). While about 6 – 8 times 
higher Ip magnitudes were expected for the UA signal due to its high physiological 
concentrations, species degradation may have occurred during sample preparation, 
transportation and preservation that may account for the decreased response [102, 
103]. A second peak of the serum background occurred at 647 mV, and this did not 
match any of the interfering species tested in the screening study. This may be a result 
of integrated signal changes in the simultaneous presence of several interfering 
species or a result of species (endogenous or exogenous) not assessed in this study. 
Lastly, current peaks that can be matched to the CySH peak pattern were not 
observed. This species may not be detectable in serum due to its low concentrations, 
overlapping with the larger UA peak, or potentially interacting (i.e., cross-reactions) 






Figure 25. Differential pulse voltammetry (DPV) of serum with and without 5.6 µM CLZ using 
sensing element A, and corresponding heat map pattern representation. All solutions were tested using 
GCE, and represent an average of duplicate measurements. 
 
In the presence of CLZ in the serum sample, a third peak at 312 mV appears in the 
DPV response (Figure 25). This peak is near the location of the CLZ peak measured 
in buffer and has about a 0.78-fold decreased Ip compared to the buffer-based 
response. Furthermore, the same peaks found in the un-spiked serum response 
remained present in the spiked serum response, with a slight decrease of the suspected 
UA peak. This decrease may be due to the cross-reactive dependencies between CLZ 
and UA.  
 




To further match the electrochemical response of un-spiked and CLZ-spiked serum, 
the CRS was utilized. The multi-dimensional tool can aid in validating the species 
that correspond with the observed patterns, by discerning and matching patterns 
across the set of sensors, for tests carried out on interfering species and simulated 
mixtures. 
 
pH Changes. Elements A – C illustrate the change in serum electrochemistry with 
varying pH at the GCE, as shown in Figure 26a. In the un-spiked serum, the 
suspected UA peak (at 248 mV, element A) follows a pH response trend (Table 7) 
matching that of the individual UA. Thus, this result further points to the likelihood of 
this peak representing the UA oxidation since the fitted values corresponding to the 
slope (proton to electron production ratio) and intercept (standard potential) of the 
Nernst equation are similar to that of UA oxidation. Similarly to the UA buffer-based 
trend, the lowest response for the primary serum peak is observed for pH 6.5, which 






Figure 26. The CRS responses of deproteinized serum are shown across the various sensing element. 
(A) Serum DPV signals at pH 6.5, 7.4 and 8.0 (elements A – C) using a GCE, (B) serum CV signal at 
pH 7.4 using GCE for cycles 1 – 3 (elements D – E), and (C) serum DPV signal with the Pt electrode 
(element F) is compared to background reactions of PBS at pH 7.4. (D) CLZ-spiked serum DPV 
signals at pH 6.5, 7.4 and 8.0 (elements A – C) using a GCE, (E) CLZ-spiked serum CV signal at pH 
7.4 using GCE for cycles 1 – 3 (elements D – E), and (E) CLZ-spiked serum DPV signal with the Pt 
electrode (element F) is compared to background reactions of serum at pH 7.4. The A – F annotations 
refer to the various elements in the CRS (Table 5), and the proteins were removed from serum 




Interestingly, the Nernst equation pH versus Ep fitting for the CLZ-spiked serum 
shows a consistent decrease in slope and intercept values of the two major peaks 
(suspected-UA and CLZ) compared to the buffer-based results, as shown in Table 7. 
This discrepancy in the pH trends may be caused by cross-reactions between UA and 
CLZ in the presence of other interfering species in this complex mixture, and further 
illustrates the dependence of the analyte measurement on other components of the 
sample. The comparison between un-spiked and CLZ-spiked serum responses at 
varying pH is illustrated in Figure 27. Notably, the highest resolution and 
differentiation of the two major peaks as well as the higher CLZ signal is seen at pH 
8.0 (element C). In contrast, buffer-based CLZ response obtained the largest peak at 
pH 7.4, which raises another difference between buffer and serum based samples that 














Uric Acid (suspected)  0.248 0.051 0.610 0.894 Deproteinized 
Serum 
CLZ-Spiked  Clozapine  0.312 0.0349 0.569 0.997 
Deproteinized 
Serum 
Uric Acid (suspected) 0.248 0.0367 0.5063 0.860 






  , equation 4), where slope values correspond to the ratio of protons to 
electrons involved in oxidation reactions and the intercept
o
E  is an estimate of the oxidation potential 
at standard conditions. Triplicate measurements were carried out for PBS-based solutions and 







CV Technique. Elements D – E illustrate the CV responses and include element ΔD, 
which represents the difference in current over a period of three CV cycles (or time). 
As seen in Figure 27a, the CV oxidation (element D) response is similar to the DPV 
response (element A). No discernable changes in the CV response over cycles 
(dynamic information, element ΔD) or reduction peak (element E) were seen in serum 
(Figure 27a). However, once CLZ was spiked into serum, CLZ peaks corresponding 
to elements ΔD and E appeared, as seen in Figure 27b. Thus, these two elements may 
be representative of UA-independent serum responses.  
 
Platinum Electrode. Element F corresponds to the Pt electrode response. As seen in 
Figure 26c, a major peak near 430 mV was observed for the un-spiked serum sample. 
The peak location is drastically different compared to the background peak observed 
at the GCE (element A). This peak shift across the two electrodes matched the 
behavior seen for the individual UA buffer-based response (Figure 27b), further 
corroborating this peak likely corresponds to UA. A difference in the current response 
Figure 27. Simplified heat map representation of electrochemical responses of the CRS elements (a-f) 
of (A) serum compared to UA individually in PBS buffer, showing the matches in their patterns, and 
of (B) serum before and after CLZ-spiking compared to the expected individual CLZ patterns, 




of PBS compared to that of serum in the range of 0 – 200 mV was observed. This 
behavior matches the behavior seen for CySH, although since a background response 
of the PBS background occurs in the same potential range, no measurements in this 
region can be directly assigned to one particular species.  
 
When CLZ was spiked into serum, no additional peaks were seen compared to un-
spiked serum. This sensing element suffers from reduced resolution compared to the 
GCE; however, it shows a characteristic signal of the UA species.  
 
4.3.2.3 Performance of Serum-Based Sensing 
Figure 28a demonstrates the increasing current response of the suspected-UA peak 
with increasing UA spiking, which provides further evidence that the background 
serum peak is indeed UA. Furthermore, this plot is representative of the UA 
variability that would likely occur from person to person. Figure 28b shows the 
increasing current response of the CLZ peak with increasing CLZ spiking, which can 
be seen to be convoluted with the UA peak, although a CLZ concentration 







Due to the proximity of the UA and CLZ peaks, variability in the dominant UA peak 
will cause variability in the CLZ peak such that the CLZ measurement is dependent 
on the UA concentration in the given sample. As seen in Figure 29for varying UA 
background levels, the sensitivity of the CLZ calibration varies, with a 1.67-fold 
decrease in sensitivity (i.e., slope) upon increasing the UA concentration by 50 µM.  
 
 
Figure 28. Concentration dependent variation for serum spiked with (A) UA at 0, 50 and 100 µM and 
(B) CLZ at 0, 4.2 and 8.3 µM. 
Figure 29. (A) CLZ calibration in serum at varying levels of UA spiked into the sample to account for 
population variability. Serum was spiked with 0 (black), 50 (blue) and 100 (red) µM UA. (B) The 







A set of 7 CRS were utilized to characterize the interaction of UA and CySH with 
CLZ and how their integrated responses in serum affect the CLZ measurement. UA 
appears to mask the CLZ peak response in buffer due its high concentration and the 
close proximity of its characteristic peak to that of CLZ. Additionally, UA’s 
antioxidant properties may prevent CLZ oxidation at the surface. CySH, on the other 
hand, showed evidence of cross-reactions with CLZ, with the detection of an 
electroactive byproduct. The presence of CySH appeared to shift the CLZ peak to 
lower potentials and decrease its peak amplitude. By understanding the pattern of 
CLZ in the presence of each interfering species, one can begin to understand how the 
CLZ response is affected by the simultaneous presence of other species.  
 
Heat map representations of the multi-dimensional responses were used to facilitate 
visual comparison among the various species. Importantly, the multiple dimensions of 
the CRS allow for comparison of characteristic patterns at 7 differential elements, 
which increases the certainty of the evaluation. Upon applying the CRS to serum 
samples, UA and CLZ patterns were matched to individual species responses across 
the elements of the CRS. The CySH pattern was not discerned in serum, likely due to 
a matrix effect such as the simultaneous presence of other species in solution that can 
affect the oxidation and degradation of this lower concentration antioxidant. Some 
differences in the patterns of UA and CLZ in buffer and in blood serum were 




cross-reactivity. These results further highlight the challenges of inter-dependence 
between the analyte and other serum components in POC blood tests, in this case 
between CLZ and UA. Nonetheless, the results demonstrate that collecting broader 
information enabled discerning of patterns in simulated and complex serum matrix. 
Furthermore, information about the specific species responsible for the major 
interference in the CLZ measurement can help in designing sensors as well as sample 






Chapter 5:  Conclusion and Future Work 
 
5.1 Conclusion 
This thesis described the analysis of endogenous interference in blood-based sensors 
using electrochemical measurements. Specifically, interference in a therapeutic drug 
monitoring sensor for CLZ antipsychotic was evaluated with the goal of identifying 
major interfering species present in the blood sample and suggesting targeted sensor 
design guidelines accordingly. First, the selectivity properties of a previously-used 
ccRCS modified sensor was qualified. The ccRCS demonstrated semi-selectivity 
properties for CLZ compared to other interfering species. However, other interfering 
species present in blood affected the ccRCS CLZ measurement.  
 
To understand which species affect the CLZ measurement in blood serum, a broader 
and more comprehensive methodology for studying interferences was developed. 
This method compared studies of individual species with studies of the complex 
blood serum matrix, where all species are present simultaneously. An initial coarse 
screening was followed by the use of a novel set of CRS for characterizing response 
patterns across the different sensors. The CRS response was shown to produce 
differential responses with the capability of providing synergistic chemical 
information and providing multi-dimensional patterns for sample comparison. By 
mapping the CRS responses onto multi-dimensional heat maps, characteristic patterns 
were compared between buffer and serum samples to discern and match patterns 




interfering species for CLZ sensing using blood serum samples. Furthermore, the 
interdependence between CLZ and other serum components (in this case, uric acid) in 
POC blood tests was highlighted. This information can aid in designing sensors as 
well as sample preparation protocols (i.e., separations, chemical treatment) that can 
improve the reliability and selectivity of the device.  Lastly, this method can be 
applied to the other electrochemical CLZ sensor materials by performing an 
abbreviated screening test using specific sensor design with simulated mixtures 
containing the electroactive species shown in Table 2. This screening method has 
broader impact because it provides a systematic process that can be applied to any 
sensor/analyte, with minor changes to the selection of interfering species of similar 
sensors.  
 
5.2 Future Work 
5.2.1 Exogenous Interfering Species Characterization 
In this study, species naturally present (endogenous) in serum were studied because 
they make up the average composition of blood in the population. Thus, samples of 
pooled serum represent this average composition and can be acquired commercially. 
On the other hand, the presence of exogenous (external species such as medications) 
species increases the complexity of serum and introduces additional potentially 
interfering species to the sample. Thus, the interference identification methodology 
shown in this thesis can be expanded to include exogenous species, and the developed 
CRS tool can be similarly applied to identify interfering exogenous species. 




identified from the common mediations used by the schizophrenia population of 
interest as well as those most commonly used by the general population, narrowed 
down based on abundance and likelihood of interference and coarse screening, and 
characterized using the CRS method shown here. The integrated understanding of 
endogenous and exogenous species in serum and their effect on the CLZ 
measurement elucidates the total expected interference in real samples of 
schizophrenia subjects, which is useful for appropriate sensor design that accounts for 
differences in the serum composition among patients. 
 
5.2.2 Microsystem Device Integration 
Translation of the CRS into a POC microfluidic system will ultimately enable real-
time treatment management in schizophrenia. This integrated system will also enable 
high-throughput testing of various serum samples. For instance, testing serum 
samples where the CLZ and UA concentrations are simultaneously varied across the 
expected physiological concentrations can be used for training chemometric models 
to take UA interference into account. Similarly, testing various schizophrenia patients 
taking CLZ with and without other medications can be used for training chemometric 
models. The high-throughput provided by microfluidic devices will allow for testing 
the large number of samples required for chemometric models. Furthermore, 
integrating material modifications, such as the carbon nanotubes will improve the 
sensitivity and lower the limit of detection of CLZ in order to achieve detection the 





5.2.3 Multivariate Chemometric Model Integration 
The ultimate sensor design is envisioned as an integrated CRS platform incorporated 
with savvy pattern recognition (i.e., chemometric) data processing that takes to 
account the measurement inter-dependence between components in serum-based 
sensors. For instance, concepts such as the electronic tongue, which has enabled 
multi-analyte assessment in complex mixtures by coupling multi-sensor responses 
with pattern recognition (i.e., chemometric) models, can be an appropriate platform 
[66, 104-108]. This method relies on CRS that each provide diverse and synergistic 
information regarding the markers of interest as well as other variable background 
signals, creating fingerprint patterns for the markers of interest. Quantitative or 
qualitative models can be applied to obtain either presence/absence information or 
concentration values [66]. Moreover, advanced models such as artificial neural 
networks are capable of being trained to a certain sample matrix, such as the 
particular baseline signal of an individual’s serum, and can account for the sample 
matrix changes that may differ from person to person [67]. Thus, the diversity of a 
sensor array provides a multi-dimensional tool that can account for variable 
component in blood.  
 
The CRS demonstrated here was designed of multiple CRS, similar to the electronic 
tongue platforms, and it can be directly used in the application of chemometric 
modeling. By training a chemometric model with varying concentrations of CLZ and 
interfering species in serum across the CRS, an integrated and quantitative analysis 




levels of serum composition (including varying UA levels) in the prediction of CLZ, 
thereby increasing the certainty of the measurement and improving the selectivity of 
the sensor system. 
 
 5.2.4 Protein Binding/Unbinding 
Because many drugs become highly bound to protein upon entering in the circulation, 
techniques for unbinding protein-bound drugs prior to measurement have the 
potential for increasing the sensitivity of the sensor. For instance, CLZ mainly binds 
to alpha-1-glycoprotein (AAG) and also binds to albumin (HSA) in blood, with a 
portion that remains free in solution. A study of the ability of electrochemical 
techniques to sense protein-bound CLZ and of various unbinding methods to free the 
protein-bound CLZ portions is proposed. For instance, CLZ can be incubated with 
proteins and filtered using a size-exclusion membrane such that only the protein-
bound CLZ portion can be separated and tested for electrochemical activity. Next, 
several unbinding techniques such as changing temperature or pH, or catalytically 
cleaving the proteins can be applied to protein-bound CLZ and characterized. 
 
 5.2.5 Identification of Biomarkers  
The CRS can be additionally used as an investigational tool to compare serum 
samples across varying populations to serve in the identification of potentially useful 
biomarkers. For instance, one can imagine a reverse application of the methodology 




to samples from healthy subjects using the CRS. By comparing the CRS patterns 
between these populations, discovery of differences among the populations and 
comparison to a buffer-based database of individual component signals can lead to 
identification of those differences. This can provide insights not only about potential 
species that can serve as biomarkers in the sample population of interest, but also 
regarding broader responses (of multiple species simultaneously) which can serve as 
an integrated biomarker pattern. Thus, pattern differences between the populations 
shown by the CRS can elucidate the presence of potential individual or combined 






POC = point-of-care 
TDM = therapeutic drug monitoring 
CLZ = clozapine 
CV = cyclic voltammetry 
DPV = differential pulse voltammetry 
RCS = redox cycling system 
ccRCS = chitosan-catechol RCS 
Ru = hexaammineruthenium 
Fc = ferrocene dimethanol 
CRS = cross-reactive sensors 
UA = uric acid 
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